scholarly journals Self-collected dried blood spots as a tool for measuring ovarian reserve in young female cancer survivors

2016 ◽  
Vol 31 (7) ◽  
pp. 1570-1578 ◽  
Author(s):  
S.C. Roberts ◽  
S.M. Seav ◽  
T.W. McDade ◽  
S.A. Dominick ◽  
J.R. Gorman ◽  
...  
Keyword(s):  
Cancer Survivors ◽  
Ovarian Reserve ◽  
Dried Blood Spots ◽  
Young Female ◽  
Blood Spots ◽  
Female Cancer Survivors

The prevalence of self-reported reproductive impairment in young female cancer survivors throughout California

2010 ◽  
Vol 94 (4) ◽  
pp. S10 ◽  
Author(s):  
J.M. Letourneau ◽  
P.M. Katz ◽  
J.F. Smith ◽  
K. Oktay ◽  
M.I. Cedars ◽  
...  
Keyword(s):  
Cancer Survivors ◽  
Young Female ◽  
Reproductive Impairment ◽  
Female Cancer Survivors

scholarly journals Toward a theoretical understanding of young female cancer survivors’ decision-making about family-building post-treatment

2020 ◽  
Vol 28 (10) ◽  
pp. 4857-4867 ◽  
Author(s):  
Catherine Benedict ◽  
Alexandria L. Hahn ◽  
Alyssa McCready ◽  
Joanne F. Kelvin ◽  
Michael Diefenbach ◽  
...  
Keyword(s):  
Decision Making ◽  
Cancer Survivors ◽  
Young Female ◽  
Post Treatment ◽  
Theoretical Understanding ◽  
Family Building ◽  
Female Cancer Survivors

scholarly journals Quality of life in female cancer survivors: is it related to ovarian reserve?

2009 ◽  
Vol 92 (3) ◽  
pp. S181-S182
Author(s):  
L.A. Kondapalli ◽  
J.P. Ginsberg ◽  
C. Carlson ◽  
M. Prewitt ◽  
C.R. Gracia
Keyword(s):  
Quality Of Life ◽  
Cancer Survivors ◽  
Ovarian Reserve ◽  
Female Cancer Survivors

scholarly journals Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing

2005 ◽  
Vol 11 (1) ◽  
pp. 69-89 ◽  
Author(s):  
Kerryn Lutchman Singh ◽  
Melanie Davies ◽  
Ratna Chatterjee
Keyword(s):  
Cancer Survivors ◽  
Ovarian Reserve ◽  
Female Cancer Survivors

scholarly journals Quality of life in female cancer survivors: is it related to ovarian reserve?

2013 ◽  
Vol 23 (2) ◽  
pp. 585-592 ◽  
Author(s):  
Laxmi A. Kondapalli ◽  
Katherine E. Dillon ◽  
Mary D. Sammel ◽  
Anushree Ray ◽  
Maureen Prewitt ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cancer Survivors ◽  
Ovarian Reserve ◽  
Female Cancer Survivors

scholarly journals Beyond fertility preservation: role of the oncofertility unit in the reproductive and gynecological follow-up of young cancer patients

2019 ◽  
Vol 34 (8) ◽  
pp. 1462-1469 ◽  
Author(s):  
Claudia Massarotti ◽  
Paola Scaruffi ◽  
Matteo Lambertini ◽  
Fausta Sozzi ◽  
Valentino Remorgida ◽  
...  
Keyword(s):  
Cancer Survivors ◽  
Cancer Patients ◽  
Fertility Preservation ◽  
Ovarian Reserve ◽  
Standard Of Care ◽  
Young Female ◽  
Cancer Relapse ◽  
Preservation Method

Abstract STUDY QUESTION Are there reasons that motivate young cancer survivors to ask for follow-up visits at an oncofertility unit? SUMMARY ANSWER Cancer survivors request oncofertility follow-up visits for the management of treatment-related side effects or ovarian reserve evaluation, even if not (or not yet) wishing for a pregnancy. WHAT IS KNOWN ALREADY Personalised oncofertility counselling before gonadotoxic therapies is considered standard of care for young women with newly diagnosed cancer. However, the long-term follow-up of these patients in an oncofertility unit is not described in the literature other than for the use of cryopreserved material. STUDY DESIGN, SIZE, DURATION We retrospectively examined rates and reasons for the first follow-up visits of 154 consecutive young female cancer patients (age range: 18–40 years) who underwent a pre-treatment consultation between January 2012 and June 2017. Demographic and clinical data were collected, as well as information about the chosen fertility preservation method, if any. PARTICIPANTS/MATERIALS, SETTING, METHODS Rates and reasons for follow-up visits were collected and expressed as percentages. Different reasons were examined in the whole cohort and stratified for type of malignancy. Possible predictive factors for return to the follow-up visit (age, nulliparity, presence of a partner, neoplasm, having cryopreserved material) were investigated through logistic regression. MAIN RESULTS AND THE ROLE OF CHANCE Out of 154 patients, 74 returned to the oncofertility unit (48.1%) for a follow-up visit. The first visit was requested mostly at the end of anticancer therapies (51.3% versus 40.5% during therapies and 8.1% after cancer relapse). Among these patients, only 10.8% returned for the first time because they were actively desiring a pregnancy. For the others, the most common reasons for consultations were management of gynecological adverse effects of therapies (29.7%) and evaluation of ovarian reserve not linked to an immediate desire for a pregnancy (39.2%). Other patients asked for contraception (4.1%), menopause counselling (5.4%), or new fertility preservation counselling because of cancer relapse (10.8%). None of the examined factors were significantly predictive of return to the oncofertility unit. LIMITATIONS, REASONS FOR CAUTION These findings represent the experience of a single centre. A longer duration of follow-up would be needed to provide more precise information on this regard. WIDER IMPLICATION OF THE FINDINGS The role of an oncofertility unit should not be limited to proposing fertility preservation procedures. In the management of young adult cancer patients, the reproductive medical specialist should be considered a key figure not only before but also during and after anticancer treatments to explore salient aspects of gynecological and reproductive health. STUDY FUNDING/COMPETING INTEREST(S) This research did not receive any specific funding. M.L. served as a consultant for Teva and received honoraria from Theramex outside the submitted work. The other authors declare no conflict of interest. TRIAL REGISTRATION NUMBER N.A.

Sign in / Sign up

Export Citation Format

Share Document